Home > Media KIt > News Room

Unaudited Financial Results For the Quarter ended 30th June, 2010

(Rs. In Lacs)

 
Sr. No. Particulars Quarter ended  30.06.2010
(Unaudited)
Quarter ended  30.06.2009
(Unaudited)
Year ended
31.03.2010
(Audited)
1(a) Net Sales/Income from Operations 4839.50 4255.39 19592.89
  (b) Other Operating Income                        -   2.52 23.27
  Total Net Operating Income (1a+1b) 4839.50 4257.91 19616.16
2 Expenditure      
  a)  (Increase) / Decrease in Stock-in-Trade & Work in Progress (525.87) (142.62) (504.84)
  b)  Consumption of Raw Materials 3651.78 3088.01 13350.19
  c)  Employee Cost 627.76 512.61 2162.43
  d)  Depreciation and Amortisation 1147.80 1137.85 4562.86
  e)  Other Expenditure 812.95 642.77 3248.75
  Total Expenditure 5714.42 5238.62 22819.39
3 Profit / (Loss) from Operations before Other Income, Interest and Exceptional Items (1-2)             (874.92) (980.71) (3203.23)
4  Other Income                         -                         -                             -  
5 Profit / (Loss) before Interest and Exceptional Items (3+4)             (874.92) (980.71) (3203.23)
6  Interest   139.48 39.24 356.59
7 Profit / (Loss) after Interest but before Exceptional Items (5-6) (1014.40) (1019.95) (3559.82)
8 Exceptional Items - Income/(Expense)                        -                         -                             -  
9 Profit / (Loss) from Ordinary Activities before Tax (7-8) (1014.40) (1019.95) (3559.82)
10 Tax Expense       
  - Fringe Benefit Tax                        -                         -                             -  
  - Corporation Tax                        -                         -                             -  
11 Profit / (Loss) from Ordinary Activities after Tax (9-10) (1014.40) (1019.95) (3559.82)
12 Extraordinary Items-Income/(Expense)                        -                         -                   3,385.77
13 Net Profit /(Loss) for the period   (1014.40) (1019.95) (174.05)
14 Share of Minority Interest                         -                             -  
15 Profit after Tax and Minority Interest (1014.40) (1019.95) (174.05)
16 Paid-up Equity Share Capital of Face Value of Rs.2/- each 8995.86 7146.06 8995.86
17 Reserves excluding Revaluation reserves                        -                         -                 24,275.49
18 a) Earning Per Share before Extraordinary Items (in Rs.) -                      
  - Basic & Diluted                   (0.23) (0.29) (0.86)
  b) Earning Per Share after Extraordinary Items (in Rs.) -                                         
  - Basic & Diluted                   (0.23) (0.29) (0.04)
19 Public Shareholding      
  - Number of Shares 294454615 200805346 294454615
  - Percentage of shareholding 65.46% 56.20% 65.46%
20 Promoters and Promoter Group Shareholding      
  a) Pledged / Encumbered      
  - Number of Shares 610000 1768856 610000
  - Percentage of shares (as a % of the total shareholding of promoter and promoter group) 0.39 1.13 0.39
  - Percentage of shares (as a % of the total share capital of the company) 0.14 0.50 0.14
  b) Non-encumbered      
  - Number of Shares 154761588 154761588 154761588
  - Percentage of shares (as a % of the total shareholding of promoter and promoter group) 99.61 98.87 99.61
  - Percentage of shares (as a % of the total share capital of the company) 34.40 43.31 34.40
Notes:
1.The above results were reviewed by the audit committee and have been approved by the Board of Directors in its meeting held on 30th July, 2010. A limited review of the same had been carried out by the statutory auditors.
2.The Company is exclusively engaged in the Pharmaceutical Business segment. Capital Employed as on June 30, 2010 is Rs.54874.13 Lacs.
3.Consolidated Income from Operatitons, Profit/(Loss) after tax and EPS for the quarter ended June 30th, 2010 stands at Rs.4906.39 Lacs,  Rs.(1156.38) Lacs & Rs. (-) 0.26 respectively.
4.There were no investor complaints pending at the beginning of the quarter. During the quarter, 15 shareholder's complaints were received and resolved.
For and on behalf of the Board
Place : New Delhi
Date : 30.07.2010
(Sushil Suri)
Chairman & Managing Director